DE2241913A1 - Oxazolinderivate, verfahren zu ihrer herstellung und ihre verwendung - Google Patents

Oxazolinderivate, verfahren zu ihrer herstellung und ihre verwendung

Info

Publication number
DE2241913A1
DE2241913A1 DE2241913A DE2241913A DE2241913A1 DE 2241913 A1 DE2241913 A1 DE 2241913A1 DE 2241913 A DE2241913 A DE 2241913A DE 2241913 A DE2241913 A DE 2241913A DE 2241913 A1 DE2241913 A1 DE 2241913A1
Authority
DE
Germany
Prior art keywords
compound
general formula
oxazoline
alkyl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2241913A
Other languages
German (de)
English (en)
Inventor
Antonin Kozlik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of DE2241913A1 publication Critical patent/DE2241913A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2241913A 1971-08-25 1972-08-25 Oxazolinderivate, verfahren zu ihrer herstellung und ihre verwendung Pending DE2241913A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3993971A GB1400448A (en) 1971-08-25 1971-08-25 Oxazoline derivatives arylalkanoic acids their preparation and therapeutic compositions containing them

Publications (1)

Publication Number Publication Date
DE2241913A1 true DE2241913A1 (de) 1973-03-08

Family

ID=10412321

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2241913A Pending DE2241913A1 (de) 1971-08-25 1972-08-25 Oxazolinderivate, verfahren zu ihrer herstellung und ihre verwendung

Country Status (11)

Country Link
US (1) US3901906A (cg-RX-API-DMAC10.html)
JP (2) JPS5336469B2 (cg-RX-API-DMAC10.html)
BE (1) BE787941A (cg-RX-API-DMAC10.html)
BR (1) BR7205790D0 (cg-RX-API-DMAC10.html)
DD (1) DD102699A5 (cg-RX-API-DMAC10.html)
DE (1) DE2241913A1 (cg-RX-API-DMAC10.html)
FR (1) FR2150841B1 (cg-RX-API-DMAC10.html)
GB (1) GB1400448A (cg-RX-API-DMAC10.html)
IL (1) IL40141A0 (cg-RX-API-DMAC10.html)
NL (1) NL7211617A (cg-RX-API-DMAC10.html)
ZA (1) ZA725785B (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4052514A (en) * 1971-03-26 1977-10-04 The Boots Company Limited Trihalosubstituted biphenylyl propionic acids
GB1437783A (en) * 1972-09-22 1976-06-03 Boots Co Ltd 2-substituted biphenylyl acetic acids and derivatives thereof
ATA785173A (de) * 1972-08-17 1975-01-15 Thomae Gmbh Dr K Verfahren zur herstellung von neuen 4-(4-biphenylyl)-4-hydroxy-buttersaeureamiden
US3953432A (en) * 1972-12-04 1976-04-27 Commercial Solvents Corporation Tranquilizers
JPS5157745A (ja) * 1974-11-18 1976-05-20 Hitachi Chemical Co Ltd Nannenseijushisoseibutsu
US4324904A (en) * 1979-12-19 1982-04-13 The Upjohn Company Processes for the preparation of hydratropic acids and esters
DE3049405A1 (de) * 1980-12-23 1982-07-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue derivate von antiphlogistisch wirksamen carbonsaeuren, ihre herstellung und medizinische anwendung
US4540795A (en) * 1983-02-25 1985-09-10 Ethyl Corporation Fluoronitroaralkyloxazolines, derivatives thereof, and nucleophilic substitution processes for preparing them
US4721790A (en) * 1983-02-25 1988-01-26 Ethyl Corporation Nucleophilic substitution process for fluoronitroaralkyloxazoline
IT1174454B (it) * 1984-01-06 1987-07-01 Montedison Spa Composti ad attivita'antidotica per la difesa di culture agrarie dall'azione di erbicidi non seletivi
USH334H (en) 1986-10-20 1987-09-01 The United States Of America As Represented By The Secretary Of The Navy Oxazole dyes
JP2898703B2 (ja) * 1990-05-24 1999-06-02 株式会社リコー 光学活性オキサゾリン化合物及びそれを含む液晶組成物
TW259693B (cg-RX-API-DMAC10.html) * 1993-08-04 1995-10-11 Du Pont
US5798376A (en) * 1994-01-17 1998-08-25 Bayer Aktiengesellschaft Azatrioxaspiroalkenes and their use as insecticidal, acaricidal and nematocidal agents
DE4401101A1 (de) * 1994-01-17 1995-07-20 Bayer Ag Phenylthio-oxazolin-Derivate
DE4401098A1 (de) * 1994-01-17 1995-07-20 Bayer Ag Diphenyloxazolin-Derivate
DE4401099A1 (de) * 1994-01-17 1995-07-20 Bayer Ag Substituierte Oxazoline
TW440429B (en) * 1994-08-12 2001-06-16 Bayer Ag Substituted biphenyloxazolines
CZ104797A3 (en) * 1994-10-06 1997-07-16 Bayer Ag Substituted biphenyloxazolines, process of their preparation, intermediates for their preparation, preparations in which said substances are comprised and their application
US5767281A (en) * 1996-02-01 1998-06-16 E. I. Du Pont De Nemours And Company Arthropodicidal oxazolines and thiazolines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3726893A (en) * 1971-09-09 1973-04-10 Robins Co Inc A H 2-(p-phenylbenzyl)oxazolines
US3737408A (en) * 1971-09-30 1973-06-05 Commercial Solvents Corp Baking enamel vehicle comprising the reaction product of an oxazoline with phenol

Also Published As

Publication number Publication date
NL7211617A (cg-RX-API-DMAC10.html) 1973-02-27
FR2150841A1 (cg-RX-API-DMAC10.html) 1973-04-13
FR2150841B1 (cg-RX-API-DMAC10.html) 1977-01-21
JPS4832866A (cg-RX-API-DMAC10.html) 1973-05-02
ZA725785B (en) 1973-09-26
BE787941A (fr) 1973-02-26
JPS5336469B2 (cg-RX-API-DMAC10.html) 1978-10-03
BR7205790D0 (pt) 1973-09-20
US3901906A (en) 1975-08-26
JPS5420494B2 (cg-RX-API-DMAC10.html) 1979-07-23
IL40141A0 (en) 1972-10-29
DD102699A5 (cg-RX-API-DMAC10.html) 1973-12-20
AU4595372A (en) 1974-02-28
GB1400448A (en) 1975-07-16
JPS53135970A (en) 1978-11-28

Similar Documents

Publication Publication Date Title
EP0004279A1 (de) Verfahren zur Herstellung von 4-Pyridon-3-carbonsäuren, 1-Cyclopropyl-4-Pyridon-3-Carbonsäurederivate und diese enthaltende Arzneimittel
DE1943265B2 (de) Isomere 3,4-Dihydro-2H-1,2-benzothiazin-1,1-dioxide
DE3129309A1 (de) Hypoglykaemische 5-substituierte oxazolidin-2,4-dione
US3901906A (en) 2-(1-(2-fluoro-4-biphenylyl)ethyl)-2-oxazoline
DE3047142A1 (de) Basische 1,7,7-trimethylbicyclo(2,2,1)heptylaether, verfahren zur herstellung derselben und diese enthaltende arzneimittel
CH624936A5 (cg-RX-API-DMAC10.html)
DE2364141A1 (de) Chromanderivate
DE3346573A1 (de) 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
DD295363A5 (de) Verfahren zur herstellung von 1-benzyl-indazol-3-yl-zwischenprodukten
EP0025192A2 (de) Substituierte Oxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
EP0046961B1 (de) Epoxi-cycloalkylalkancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung sowie sie enthaltende Arzneimittel
DE69708130T2 (de) A-oxo-butansäuren enthaltende pharmazeutische zusammensetzung
DE2448438A1 (de) 2-substituierte und 2,2-disubstituierte eckige klammer auf 1,3-dioxoindanyloxy(oder -thio) eckige klammer zu -alkancarbonsaeuren und verfahren zur herstellung derselben
EP0380712A1 (de) Verfahren zur Herstellung von 2,6-Dichlordiphenylaminessigsäurederivaten
DE3532279A1 (de) 1,4-benzoxathiin-derivate
DE2854877A1 (de) N-substituierte omega-thiobutyramide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0061056A1 (de) 5,6-Dimethyl-pyrrolo(2,3-b)pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0279162B1 (de) Neue Carbonsäurederivate, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten
EP0072960A2 (de) 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2056173A1 (de) 3,5 Diphenyl 4 pyrazolessigsaure. ihre m 1 Stellung substituierten Derivate und Verfahren zur Herstellung dieser Verbin düngen
DE3020421A1 (de) Imidazoazolalkensaeureamide, neue zwischenprodukte zu ihrer herstellung, ihre herstellung und ihre verwendung in arzneimitteln
EP0371342B1 (de) 2-Halogensubstituierte N-Indolylethyl-sulfonsäureamide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0339342A1 (de) N-Substituierte N-Amino-pyrrole
DE2412388A1 (de) Dibenzothiophenderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE2214561A1 (de) 2-Substituierte Propionsäuren, Derivate derselben und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
OD Request for examination
OHJ Non-payment of the annual fee